Bioscience sector shaping the future of new centre of excellence

A series of focus groups is being held with key stakeholders to determine priorities for the National Horizons Centre (NHC), which opens in the spring.
The NHC is a £22.3 million state-of-the-art bioscience education, training, research and innovation facility at Teesside University’s Darlington campus on Central Park.
It will house academics and business development staff from Teesside University, working in partnership with regional, national and international industry players including Fujifilm Diosynth Biotechnologies and the Centre for Process Innovation (CPI), to provide specialist education, training and professional development for the current and future workforce, and to promote industry focused innovation and research.
As part of its focus on workforce skills, the University has been working with businesses including Fujifilm Diosynth, Quorn, Hart Biologicals, GlaxoSmithKline and AstraZeneca UK, to identify current and future skills gaps. The information from the focus groups will be used to develop a series of Continuing Professional Development (CPD) courses which the NHC will offer to businesses.
Laura Woods, Director of Academic Enterprise at Teesside University, said: “The NHC will play a vital part in the University’s mission to help drive economic growth, here in the Tees Valley and nationally. We want to be confident that the NHC directly addresses the industry’s needs."
“It is fantastic that so many key players in this innovative and exciting sector are already involved, and we look forward to working with even more companies in helping the Tees Valley meet the challenges of the government’s industrial strategy.”
Needs already identified by focus groups include more training on quality assurance and project management, and graduate ‘soft skills’ such as scientific writing and business awareness.
Discussions have also been held about industrial skills lacking in the region, and the state-of-the art equipment that will feature in the NHC.
The NHC is due to open in spring 2019. It has been financially supported by the Local Growth Fund, via the Tees Valley Combined Authority, and the European Regional Development Fund.
Sign up for your free email newsletter
The Local Growth Fund contribution of £17.5 million represents the single biggest investment by the fund in the Tees Valley.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CI KOREA POSTPONEMENT OF THE EXHIBITION
-
Libya’s Largest Refinery Faces Full Shutdown After Five Rounds of Airstrikes
-
SIBUR’s Massive Siberian Petrochemical Complex Shuts After Drone Attack, LPG Supply Disrupted
-
Lianolong Bets Big on Electronic Adhesives with $50M Strategic Stake in Sidofu
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
Crude Tanker Freight From the Americas to Asia Tops $80 Million per Voyage Amid Global Shipping Crunch
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
Recommend Reading
-
Behind Arkema’s ¥430 Million Claim: A Patent War Over Acrylic Acid Is Tearing Off the “Technical Fig Leaf” of China’s Chemical Giants
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
-
This Week's Styrene Market Fluctuates and Declines (10.12-10.16)
-
Business Society October 12, 2026 Maleic Anhydride Trend Analysis: Volatility
-
Return from Holiday, Shandong Cyclohexanone Market Continues to Rise
-
Bivalirudin: Medical Uses, Properties, and Safety
-
Business Society October 13, 2026 DOP Trend Analysis: Strongly Bullish